Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

3IGP

Structure of inhibitor binding to Carbonic Anhydrase II

3IGP の概要
エントリーDOI10.2210/pdb3igp/pdb
分子名称Carbonic anhydrase 2, ZINC ION, 6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamide, ... (5 entities in total)
機能のキーワードcarbonic anhydrase inhibitors, isoquinolines, lyase, acetylation, cytoplasm, disease mutation, metal-binding, polymorphism, zinc
由来する生物種Homo sapiens (human)
タンパク質・核酸の鎖数1
化学式量合計30083.30
構造登録者
Gitto, R.,Agnello, S.,Brynda, J.,Mader, P.,Supuran, C.T.,Chimirri, A. (登録日: 2009-07-28, 公開日: 2010-03-09, 最終更新日: 2023-11-01)
主引用文献Gitto, R.,Agnello, S.,Ferro, S.,De Luca, L.,Vullo, D.,Brynda, J.,Mader, P.,Supuran, C.T.,Chimirri, A.
Identification of 3,4-Dihydroisoquinoline-2(1H)-sulfonamides as Potent Carbonic Anhydrase Inhibitors: Synthesis, Biological Evaluation, and Enzyme-Ligand X-ray Studies.
J.Med.Chem., 2010
Cited by
PubMed Abstract: Following previous studies we herein report the exploration of the carbonic anhydrase (CA, EC 4.2.1.1) inhibitory effects and enzyme selectivity of a small class of 1-(cyclo)alkylisoquinolines containing a sulfonamide function considered a key feature for inhibiting CA. The results of enzymatic assays against human (h) CA isoforms, hCA I and hCA II (cytosolic, ubiquitous enzymes), hCA IX (transmembrane, tumor-associated), and hCA XIV (transmembrane), suggested that the presence of C-1 small substituents on isoquinoline scaffold controls both inhibitory potency and selectivity. Some derivatives showed potent hCA IX and hCA XIV inhibitory effects at nanomolar concentrations as well as low affinity for the ubiquitous hCA II. Moreover, we report the X-ray crystal structure of one of these derivatives in complex with dominant human isoform II, thus confirming the sulfonamide--zinc interactions. Finally, the results of docking experiments suggested the hypothetic interactions in the catalytic binding site for the most active and selective hCA IX and hCA XIV inhibitor.
PubMed: 20170095
DOI: 10.1021/jm9014026
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.65 Å)
構造検証レポート
Validation report summary of 3igp
検証レポート(詳細版)ダウンロードをダウンロード

248636

件を2026-02-04に公開中

PDB statisticsPDBj update infoContact PDBjnumon